Balance Sheets (USD $)	Jun. 30, 2014 Unaudited	Dec. 31, 2013 Audited
Cash and cash equivalents	$ 61,054	$ 22,132
Due from related party	200,199	295,912
Promissory note	2,000	3,000
Total Current Assets	263,254	321,044
Patents	7,000	7,000
Total Assets	270,254	328,044
Accounts payable	797,908	797,908
Accrued expenses	2,094,508	1,986,726
Derivative liability	75,722	429,296
Notes payable	773,279	773,279
Notes payables	325,000	225,000
Convertible notes payable, net	32,504	117,534
Total Current Liabilities	4,098,921	4,329,743
Common stock (Par value $0.001 authorized 100,000,000 shares, issued and outstanding 96,554,322 and 93,209,823 at June 30, 2014 and December 31, 2013, respectively)	96,554	93,210
Additional paid in capital	32,220,773	30,078,730
Common stock-warrants	97,869	97,869
Deferred compensation		(12,609)
Accumulated deficit	(36,243,863)	(34,258,898)
Total stockholders deficit	(3,828,666)	(4,001,698)
Total Liabilities and stockholders deficit	$ 270,254	$ 328,044